Добавил:
Sekretar
kiopkiopkiop18@yandex.ru
t.me/Prokururor I Вовсе не секретарь, но почту проверяю
Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз:
Предмет:
Файл:Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_5990_Библиотеки_им_академика_М_И_Перельмана.pdf
33Introduction to Social Pharmacy
3. End desertification and restore degraded land.
4. Ensure the conservation of mountain ecosystems.
5. Protect biodiversity and natural habitats.
6. Protect access to genetic resources and fair sharing of
the benefits.
7. Eliminate poaching and trafficking of protected species.
8. Prevent invasive alien species on land and in water
ecosystems.
9. Integrate ecosystem and biodiversity in governmental
planning.
10. Increase financial resources to conserve and sustain-
ably use ecosystems and biodiversity.
11. Combat global poaching and trafficking.
Goal 16: Peace, justice, and strong institutions: ”Promote
peaceful and inclusive societies for sustainable development,
provide access to justice for all, and build effective, accountable,
and inclusive institutions at all levels”.
Indicators:
1. Rates of birth registration.
2. Prevalence of bribery
Targets:
1. Reduce violence.
2. Protect children from abuse, exploitation, trafficking
and violence.
3. Promote the rule of law and ensure equal access to
justice.
4. Combat crime and illicit financial and arms flows.
5. Reduce corruption and bribery.
6. Develop effective, accountable, and transparent
institutions.
7. Ensure responsive decision-making.
8. Strengthen the participation in global governance.
9. Provide universal legal identity.
10. Ensure public access to information and protect funda-
mental freedoms.
34 Social Pharmacy
11. Strengthen national institutions to prevent violence and
combat crime and terrorism.
12. Promote and enforce non-discriminatory laws and
policies.
Goal 17: Partnership for the goals: “Strengthen the means of
implementation and revitalize the global partnership for
sustainable development”.
Indicators:
1. Increasing international cooperation.
2. Developing multi-stakeholder partnerships to share
knowledge, expertise, technology, and financial
support.
Targets:
1. Improving North-South and South-South cooperation,
and public-private partnerships.
2. Improved and more equitable trade.
3. Coordinated investment initiatives to promote
sustainable development across borders.
4. Strengthening and streamlining cooperation between
nation-states, both developed and developing.
5. Promote international trade and an equitable trading
system.
To achieve sustainable development the economic, socio-
political, and environmental dimensions need to come together.
The economic, socio-political, and environmental dimensions
are all critically important and interdependent.
International Pharmaceutical Federation (FIP) Goals
FIP is recognized as the leader of pharmacy at a global level.
FIP is a non-governmental organization/(NGO) in official
relations with the World Health Organization. It is the global
body representing over four million pharmacists, pharma-
ceutical scientists, and pharmaceutical educators through 153
National organizations, academic institutional members, and
individual members. The International Pharmaceutical
Federation (FIP) in September 2020 launched FIP development
Goals, which are a key resource for transforming the pharmacy
profession over the next decade globally, regionally, and
nationally.
35Introduction to Social Pharmacy
Fig. 1.2: Wedding cake model of economic, social, and ecological aspects of sustainable development goals
36 Social Pharmacy
Table 1.2: Sustainable development goals (SDGs)
SDGs No. Goal
1 No poverty
2 Zero hunger
3 Good health
4 Quality education
5 Gender equality and well-being
6 Clean water and sanitation
7 Affordable and clean energy
8 Decent work and economic growth
9 Industry, innovation and infrastructure
10 Reducing inequality
11 Sustainable cities and communities
12 Responsible consumption and production
13 Climate action
14 Life below water
15 Life on land
16 Peace, justice, and strong institutions
17 Partnerships for the goals
The FIP development goals are to transform global
pharmacy.
Fig. 1.3: FIP development goals to transform global pharmacy
37Introduction to Social Pharmacy
Each of the FIP development goals is composed of
3 elements: Practice, science, and workforce. Each of the 21
FIP DGs provides a focus for transforming global pharmacy.
The FIP DGs serve as a systematic framework that guides the
basis for needs assessment and form a foundation for
transformation mapping.
Fig. 1.4: FIP development goals
38 Social Pharmacy
Table 1.3: FIP development goals
S. FIP development Elements
No. goals
Workforce Practice Science
1. Academic capacity Engagement with pharmaceu- Capacity for in-practice Institutional academic
tical higher education develop- training and development capacity to deliver quality
ment policies and ready access linked with education pharmaceutical sciences
to leaders in all sectors of providers; pathways for education and training for
pharmacy practice and professional advancement pharmacists and pharma-
pharmaceutical science to from foundation training ceutical scientists who
support supply-side workforce through to advanced prac contribute to patient care,
development agendas tice and/or specialization discoveries and develop-
ment, clinical utilization,
marketing regulations,
and the economic assess-
ment of health products
2. Early career Engagement with pharmaceu- Training strategy and infra- Education and training of
training strategy tical higher foundation training structures providing struc- graduate/postgraduate
infrastructures in place for the tured journeys for early students and early career
early post-registration (post- career pharmacy practi- pharmaceutical scientists
licensing) years of the pharma- tioners including pharmacy to advance their skills in
ceutical workforce as a basis for support workers linked basic, translational, clini-
consolidating initial education towards advanced practice cal and regulatory
and training and progressing and specialization frame- sciences
the novice workforce towards works and professional
advanced practice recognition and certification
(Contd.)
39Introduction to Social Pharmacy
S. FIP development Elements
No. goals
Workforce Practice Science
3. Quality assurance Transparent, contemporary, and Transparent, contemporary, Quality and integrity in
innovative processes for the and innovative processes pharmaceutical research,
quality assurance of needs-based for the quality assessment, development, manufactur-
education and training systems monitoring, and improve- ing, and regulations to
ment of services in practice assure access to safe and
effective medical products
globally.
4. Advanced and Education and training infra- Sector-specific competency Education, training, and
specialist structures are in place for the and development frame- mentoring to foster inno-
development recognized advancement of the works and infrastructures vation and expertise in
pharmaceutical workforce as for advanced and/or pharmaceutical sciences
a basis for enhancing patient specialized pharmacy
care and health system practice and people-
deliverables centered services.
5. Competency Clear and accessible develop- Clearly defined develop- A framework describing
development mental frameworks describing mental frameworks for competencies for all stages
competencies and scope of practitioners describing of professional careers in
practice for all stages of profes- competencies linked to pharmaceutical sciences
sional careers. This should professional services
include leadership development delivered in practice
frameworks for the pharmaceu-
tical workforce
6. Leadership Strategies and programs in place Strategies and programs Strategies and programs
development that develop professional leader- for professional leadership for scientific leadership are
(Contd.)
40 Social Pharmacy
Table 1.3: FIP development goals (contd.)
S. FIP development Elements
No. goals
Workforce Practice Science
ship skills (including clinical and incorporate team- and in place to sustain excel-
executive leadership) for all collaborative performance, lence in pharmaceutical
stages of career development, service development in line sciences research, develop-
including pharmaceutical with local needs, and clini- ment, manufacturing, and
sciences and initial education cal leadership which regulations
and training demonstrates responsi-
bility, accountability,
decision-making ownership,
and professional autonomy
7. Advancing Inte- A patient-centered and integra- A people-centred and inte- Scientific strategies to
grated Services ted health services foundation grated healthcare provision evaluate expanded
for workforce development, that is based on an inter- professional pharmacy
relevant to social determinants professional and cross- services and programs,
of health and needs-based setting seamless continuum including translational
approaches to workforce including pharmacist-deli- and reverse-translational
development vered professional services research
8. Working with Identifiable elements of collabo- Identifiable elements of Transdisciplinary collabo-
others rative working and interprofes- inter- and intra-professio- ration to advance
sional education and training nal collaboration and multi- education, research, deve-
which should be a feature of all disciplinary healthcare, lopment, manufacturing,
workforce development delivered through cohesive and regulations that
programmes and policies and interdependent teams collectively improve access
working across interfaces to medical products
and transitions of care
(Contd.)
41Introduction to Social Pharmacy
S. FIP development Elements
No. goals
Workforce Practice Science
9. Continuing All professional development In-practice and needs- Integrate professional
professional activity is linked with needs- based continuing profes- development as an
development based health policy initiatives sional development (CPD) essential component of
strategies and pharmaceutical career and continuing education advanced pharmaceutical
development pathways (CE) are linked to career sciences
development pathways
and practice frameworks
10. Equity and Clear strategies for addressing Clear strategies for equity Equity in the global capa-
equality equity and diversity inequalities and diversity in pharma- city of pharmaceutical
in pharmaceutical workforce ceutical services delivery, sciences training, research
development, continued edu- service access, and service infrastructure, develop-
cation and training, and career impact so that all people ment and manufacturing
progression opportunities have access to quality capabilities, and evidence-
pharmaceutical care based regulatory oversight
11. Impact and Evidence of the impact of the Evidence of the impact of Strategies and programs
outcomes pharmaceutical workforce pharmaceutical services in are in place to enable
within health systems and terms of health outcomes timely access to safe,
health improvement and quality of life, improved effective, and affordable
efficiency of health systems, medical products
and sustainability
12. Pharmacy A national strategy and corres- A comprehensive national Data-driven decision
intelligence ponding actions to collate and strategy to collate, share, strategies to accelerate
share workforce data and work- and utilize intelligence on pharmaceutical research,
force planning activities (skill service provision, develop- development, manufac-
(Contd.)
42 Social Pharmacy
Table 1.3: FIP development goals (contd.)
S. FIP development Elements
No. goals
Workforce Practice Science
mixes, advanced and specialist ment, delivery, and needs turing, and market
practice, capacity). Without to inform evidence-based approval of medical
workforce intelligence data pharmaceutical services products to maximize
there can be no strategic work- development, policy-mak- clinical benefits for
force development ing, and funding decisions individual patients
13. Policy develop- Clear and manageable strategies Clear pharmacy-led strate- Defined strategies to
ment to implement comprehensive gies to develop and imple- implement needs-based
needs-based development of ment needs and evidence- pharmaceutical policies
the pharmaceutical workforce based practice-related that drive national
throughout the entire profes- policies on service imple- research priorities, intel-
sional career life cycle mentation, integration, and lectual property protec-
remuneration, aligned with tion, licensing, and pricing
broader national health decisions for medical
policies and priorities products
14. Medicines Strategies and systems are in Strategies and systems in Encourage the provision of
expertise place to prepare and train a place for pharmaceutical science-based information
workforce that can deliver expert information and on medicines
quality medicines expertise advice provision to patients,
formal and informal care-
givers, healthcare profes-
sionals, and relevant
agencies and stakeholders
15. People-centred Strategies in place to develop Collaborative inter-profes- Capacity to monitor and
care pharmaceutical education and sional strategies and people- understand health-related
(Contd.)